Cypress Funds Cut Monro Muffler Brake (Call) (MNRO) Stake By $1.66 Million; Merck Sharp & Dohme Has 0.94 Sentiment

May 23, 2018 - By Louis Casey

Monro, Inc. (NASDAQ:MNRO) Logo

Merck Sharp & Dohme Corp (MRK) investors sentiment decreased to 0.94 in Q4 2017. It’s down -0.12, from 1.06 in 2017Q3. The ratio turned negative, as 681 hedge funds increased and started new holdings, while 725 decreased and sold their holdings in Merck Sharp & Dohme Corp. The hedge funds in our database now have: 1.93 billion shares, down from 1.96 billion shares in 2017Q3. Also, the number of hedge funds holding Merck Sharp & Dohme Corp in top ten holdings decreased from 80 to 44 for a decrease of 36. Sold All: 94 Reduced: 631 Increased: 558 New Position: 123.

Cypress Funds Llc decreased Monro Muffler Brake Inc (Call) (MNRO) stake by 4.57% reported in 2017Q4 SEC filing. Cypress Funds Llc sold 29,700 shares as Monro Muffler Brake Inc (Call) (MNRO)’s stock declined 11.02%. The Cypress Funds Llc holds 620,000 shares with $35.31 million value, down from 649,700 last quarter. Monro Muffler Brake Inc (Call) now has $1.77B valuation. The stock increased 3.26% or $1.7 during the last trading session, reaching $53.85. About 204,790 shares traded. Monro, Inc. (NASDAQ:MNRO) has declined 0.29% since May 23, 2017 and is downtrending. It has underperformed by 11.84% the S&P500.

More important recent Monro, Inc. (NASDAQ:MNRO) news were published by: which released: “Monro’s (MNRO) CEO Brett Ponton Hosts Investor Day (Transcript)” on May 21, 2018, also published article titled: “Spotlight On Gambling Reset And Banking Bill”, published: “The Week Ahead: Target, Best Buy Help Close Out Earnings Season” on May 21, 2018. More interesting news about Monro, Inc. (NASDAQ:MNRO) was released by: and their article: “23 Stocks Moving In Monday’s Pre-Market Session” with publication date: May 21, 2018.

Investors sentiment increased to 1.43 in Q4 2017. Its up 0.01, from 1.42 in 2017Q3. It increased, as 17 investors sold MNRO shares while 51 reduced holdings. 33 funds opened positions while 64 raised stakes. 35.34 million shares or 0.96% less from 35.68 million shares in 2017Q3 were reported. Glenmede Com Na accumulated 2,705 shares. Price T Rowe Assocs Inc Md accumulated 1.99M shares or 0.02% of the stock. Amalgamated National Bank & Trust, a New York-based fund reported 4,652 shares. The Missouri-based Scout Invs has invested 0.14% in Monro, Inc. (NASDAQ:MNRO). Zurcher Kantonalbank (Zurich Cantonalbank), a Switzerland-based fund reported 1,960 shares. Walleye Trading Limited Liability Co holds 4,544 shares or 0% of its portfolio. Moreover, First Tru Advsr Lp has 0% invested in Monro, Inc. (NASDAQ:MNRO) for 14,313 shares. Goldman Sachs Gru holds 0% of its portfolio in Monro, Inc. (NASDAQ:MNRO) for 106,080 shares. Crawford Investment Counsel holds 76,083 shares or 0.13% of its portfolio. Texas Permanent School Fund invested in 0.02% or 22,153 shares. Fenimore Asset Mngmt Inc has 0.55% invested in Monro, Inc. (NASDAQ:MNRO) for 254,995 shares. Ontario – Canada-based Canada Pension Plan Inv Board has invested 0% in Monro, Inc. (NASDAQ:MNRO). 56,051 are owned by Prudential Finance. Pennsylvania Tru Company reported 10,469 shares. State Bank Of Montreal Can holds 0.01% or 265,928 shares.

Since February 5, 2018, it had 0 insider purchases, and 2 insider sales for $708,100 activity. 10,000 shares valued at $555,100 were sold by MCCLUSKI STEPHEN C on Monday, February 5. Mulholland Maureen also sold $153,000 worth of Monro, Inc. (NASDAQ:MNRO) shares.

Among 14 analysts covering Monro Muffler Brake (NASDAQ:MNRO), 5 have Buy rating, 0 Sell and 9 Hold. Therefore 36% are positive. Monro Muffler Brake had 31 analyst reports since August 5, 2015 according to SRatingsIntel. The stock of Monro, Inc. (NASDAQ:MNRO) has “Neutral” rating given on Monday, September 28 by CL King. KeyBanc Capital Markets maintained the shares of MNRO in report on Tuesday, October 24 with “Hold” rating. KeyBanc Capital Markets downgraded Monro, Inc. (NASDAQ:MNRO) on Wednesday, August 19 to “Sector Weight” rating. The stock has “Buy” rating by Jefferies on Wednesday, June 14. The rating was initiated by Sterne Agee CRT with “Buy” on Tuesday, October 20. The stock of Monro, Inc. (NASDAQ:MNRO) has “Buy” rating given on Tuesday, September 15 by Jefferies. As per Wednesday, August 5, the company rating was upgraded by Evercore. The rating was maintained by Stephens with “Hold” on Tuesday, April 17. Oppenheimer maintained the stock with “Buy” rating in Thursday, July 20 report. The stock has “Equal-Weight” rating by Stephens on Thursday, June 29.

Pathstone Family Office Llc holds 19.55% of its portfolio in Merck & Co., Inc. for 72,976 shares. Srb Corp owns 1.88 million shares or 13.61% of their US portfolio. Moreover, Healthcor Management L.P. has 7.14% invested in the company for 3.90 million shares. The Arkansas-based Foundation Resource Management Inc has invested 6.04% in the stock. Sector Gamma As, a Norway-based fund reported 558,500 shares.

Merck & Co., Inc. provides healthcare solutions worldwide. The company has market cap of $158.77 billion. It operates in four divisions: Pharmaceutical, Animal Health, Healthcare Services, and Alliances divisions. It has a 67.83 P/E ratio. The firm offers therapeutic agents to treat cardiovascular, type 2 diabetes, asthma, nasal allergy symptoms, allergic rhinitis, chronic hepatitis C virus, HIV-1 infection, fungal and intra-abdominal infections, hypertension, arthritis and pain, inflammatory, osteoporosis, and fertility diseases.

Ratings analysis reveals 86% of Merck’s analysts are positive. Out of 7 Wall Street analysts rating Merck, 6 give it “Buy”, 1 “Sell” rating, while 0 recommend “Hold”. MRK was included in 7 notes of analysts from September 9, 2016. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Underperform” rating by Jefferies on Monday, December 19. The company was maintained on Friday, September 9 by Barclays Capital. As per Thursday, January 12, the company rating was upgraded by Guggenheim. On Thursday, October 13 the stock rating was upgraded by Bank of America to “Buy”. The stock of Merck & Co., Inc. (NYSE:MRK) has “Overweight” rating given on Thursday, January 12 by Piper Jaffray. The stock of Merck & Co., Inc. (NYSE:MRK) earned “Buy” rating by Bryan Garnier & Cie on Friday, January 13. As per Thursday, January 12, the company rating was upgraded by Morgan Stanley.

The stock increased 0.97% or $0.565 during the last trading session, reaching $59.015. About 4.49M shares traded. Merck & Co., Inc. (MRK) has declined 14.94% since May 23, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Merck & Co., Inc. (NYSE:MRK) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: